Development and Performance Evaluation of a Tandem Mass Spectrometry Assay for 4 Adrenal Steroids
- 1 August 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (8) , 1559-1567
- https://doi.org/10.1373/clinchem.2006.068445
Abstract
Background: Congenital adrenal hyperplasia is a group of autosomal recessive disorders caused by a deficiency of 1 of 4 enzymes required for the synthesis of glucocorticoids, mineralocorticoids, and sex hormones. Analysis of 11-deoxycortisol (11DC), 17-hydroxyprogesterone (17OHP), 17-hydroxypregnenolone (17OHPr), and pregnenolone (Pr) in blood allows detection of these enzyme defects. Methods: The steroids were extracted from 200 μL of serum or plasma by solid-phase extraction, derivatized to form oximes, and extracted again with methyl t-butyl ether. Instrumental analysis was performed on an API 4000 tandem mass spectrometer with electrospray ionization in positive mode and multiple reaction-monitoring acquisition. Results: The limits of detection were 0.025 μg/L for 11DC, 17OHP, and Pr and 0.10 μg/L for 17OHPr. The method was linear to 100 μg/L for 11DC, 17OHP, and Pr, respectively, and to 40 μg/L for 17OHPr. Within- and between-run (total) imprecision (CVs) were 72 h. Conclusions: The detection limit and selectivity of this method and its small sample volume requirement allow analysis of endogenous concentrations of adrenal steroids in serum or plasma from children and adults. The method thus has an important potential role in the evaluation of the status of 4 of the enzymes involved in adrenal steroid biosynthesis.Keywords
This publication has 39 references indexed in Scilit:
- Performance Characteristics of a Novel Tandem Mass Spectrometry Assay For Serum TestosteroneClinical Chemistry, 2006
- Emerging Role for Tandem Mass Spectrometry in Detecting Congenital Adrenal HyperplasiaClinical Chemistry, 2004
- Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass SpectrometryClinical Chemistry, 2004
- The Diagnosis of Congenital Adrenal Hyperplasia in the Newborn by Gas Chromatography/Mass Spectrometry Analysis of Random Urine SpecimensJournal of Clinical Endocrinology & Metabolism, 2002
- Rapid screening assay of congenital adrenal hyperplasia by measuring 17α‐hydroxyprogesterone with high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spotsJournal of Clinical Laboratory Analysis, 2002
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from SpainJournal of Clinical Endocrinology & Metabolism, 2000
- Prevalence of 3β-hydroxysteroid dehydrogenase–deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excessAmerican Journal of Obstetrics and Gynecology, 1999
- Identification of 17‐hydroxyprogesterone and other steroid hormones in saliva from a normal child and patients with congenital adrenal hyperplasia by plasmaspray liquid chromatography/mass spectrometryBiomedical Chromatography, 1990
- Pitfalls in the Etiological Diagnosis of Congenital Adrenal Hyperplasia in the Early Neonatal PeriodHormone Research, 1982
- PLASMA PREGNENOLONE, PROGESTERONE, 17‐HYDROXYPROGESTERONE, TESTOSTERONE AND 5α‐DIHYDROTESTOSTERONE IN DIFFERENT TYPES OF CONGENITAL ADRENAL HYPERPLASIAClinical Endocrinology, 1975